---
title: "Sertindole - Schizophrenia"
sidebar: mydoc_sidebar
permalink: db06144-mesh-d012559-1.html
toc: false 
---


Path ID: `DB06144_MESH_D012559_1`
{% include image.html url="images/db06144-mesh-d012559-1.png" file="db06144-mesh-d012559-1.png" alt="db06144-mesh-d012559-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C066304 | sertindole | Drug |
| UniProt:P14416 | D(2) dopamine receptor | Protein |
| UniProt:P28223 | 5-hydroxytryptamine receptor 2A | Protein |
| UniProt:P28335 | 5-hydroxytryptamine receptor 2C | Protein |
| UniProt:P35348 | Alpha-1A adrenergic receptor | Protein |
| UniProt:P25100 | Alpha-1D adrenergic receptor | Protein |
| UniProt:P35368 | Alpha-1B adrenergic receptor | Protein |
| GO:0014046 | dopamine secretion | BiologicalProcess |
| GO:0014047 | glutamate secretion | BiologicalProcess |
| GO:0004952 | dopamine neurotransmitter receptor activity | MolecularActivity |
| UBERON:0001910 | medial forebrain bundle | GrossAnatomicalStructure |
| HP:0000709 | Psychosis | PhenotypicFeature |
| HP:0002071 | Abnormality of extrapyramidal motor function | PhenotypicFeature |
| MESH:D012559 | Schizophrenia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Sertindole | DECREASES ACTIVITY OF | D(2) Dopamine Receptor |
| Sertindole | DECREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 2C |
| Sertindole | DECREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 2A |
| Sertindole | DECREASES ACTIVITY OF | Alpha-1B Adrenergic Receptor |
| Sertindole | DECREASES ACTIVITY OF | Alpha-1A Adrenergic Receptor |
| Sertindole | DECREASES ACTIVITY OF | Alpha-1D Adrenergic Receptor |
| Alpha-1A Adrenergic Receptor | CORRELATED WITH | Abnormality Of Extrapyramidal Motor Function |
| Alpha-1D Adrenergic Receptor | CORRELATED WITH | Abnormality Of Extrapyramidal Motor Function |
| Alpha-1B Adrenergic Receptor | CORRELATED WITH | Abnormality Of Extrapyramidal Motor Function |
| Abnormality Of Extrapyramidal Motor Function | CORRELATED WITH | Schizophrenia |
| 5-Hydroxytryptamine Receptor 2C | NEGATIVELY REGULATES | Dopamine Secretion |
| 5-Hydroxytryptamine Receptor 2A | POSITIVELY REGULATES | Dopamine Secretion |
| 5-Hydroxytryptamine Receptor 2A | POSITIVELY REGULATES | Glutamate Secretion |
| Glutamate Secretion | POSITIVELY CORRELATED WITH | Dopamine Neurotransmitter Receptor Activity |
| Dopamine Neurotransmitter Receptor Activity | POSITIVELY CORRELATED WITH | Psychosis |
| D(2) Dopamine Receptor | POSITIVELY REGULATES | Dopamine Secretion |
| Dopamine Secretion | LOCATED IN | Medial Forebrain Bundle |
| Dopamine Secretion | NEGATIVELY CORRELATED WITH | Schizophrenia |
| Medial Forebrain Bundle | POSITIVELY CORRELATED WITH | Schizophrenia |
| Psychosis | POSITIVELY CORRELATED WITH | Schizophrenia |
|---------|-----------|---------|

Reference: 
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL12713/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL12713/)
  - [https://go.drugbank.com/drugs/DB06144](https://go.drugbank.com/drugs/DB06144)
  - [https://pubmed.ncbi.nlm.nih.gov/24300463/](https://pubmed.ncbi.nlm.nih.gov/24300463/)
  - [https://pubmed.ncbi.nlm.nih.gov/8778681/](https://pubmed.ncbi.nlm.nih.gov/8778681/)
